Sana Bio (SANA) Stock Forecast, Price Target & Predictions

SANA Stock Forecast

Sana Bio stock forecast is as follows: an average price target of $8.00 (represents a 216.21% upside from SANA’s last price of $2.53) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

SANA Price Target

The average price target for Sana Bio (SANA) is $8.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $8.00 to $8.00. This represents a potential 216.21% upside from SANA's last price of $2.53.

SANA Analyst Ratings

Buy

According to 3 Wall Street analysts, Sana Bio's rating consensus is 'Buy'. The analyst rating breakdown for SANA stock is 0 'Strong Buy' (0.00%), 3 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Sana Bio Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Nov 05, 2024	Emily Bodnar	H.C. Wainwright	$8.00	$3.39	135.99%	216.21%
Jan 16, 2024	Emily Bodnar	H.C. Wainwright	$12.00	$6.36	88.68%	374.31%

Row per page

Go to

The latest Sana Bio stock forecast, released on Nov 05, 2024 by Emily Bodnar from H.C. Wainwright, set a price target of $8.00, which represents a 135.99% increase from the stock price at the time of the forecast ($3.39), and a 216.21% increase from SANA last price ($2.53).

Sana Bio Price Target by Period

	1M	3M	12M
# Anlaysts	1	1	2
Avg Price Target	$8.00	$8.00	$10.00
Last Closing Price	$2.53	$2.53	$2.53
Upside/Downside	216.21%	216.21%	295.26%

In the current month, the average price target of Sana Bio stock is $8.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 216.21% increase as opposed to Sana Bio's last price of $2.53. This month's average price target is down 0.00% compared to last quarter, and down -20.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Nov 05, 2024	H.C. Wainwright	Buy	Buy	Hold
Nov 05, 2024	JMP Securities	-	Perform	Downgrade
Aug 09, 2024	Citigroup	Buy	Buy	Hold
Jun 26, 2024	Rodman & Renshaw	-	Buy	Initialise
Jan 16, 2024	H.C. Wainwright	-	Buy	Upgrade

Row per page

Go to

Sana Bio's last stock rating was published by H.C. Wainwright on Nov 05, 2024. The company gave SANA a "Buy" rating, the same as its previous rate.

Sana Bio Financial Forecast

Sana Bio Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Revenue	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-
# Analysts	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-

Sana Bio's average Quarter revenue forecast for undefined based on undefined analysts is $NaN, with a low forecast of $NaN, and a high forecast of $NaN. SANA's average Quarter revenue forecast represents a NaN% decrease compared to the company's last Quarter revenue of $NaN (undefined).

Sana Bio EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-

undefined analysts predict SANA's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Sana Bio's previous annual EBITDA (undefined) of $NaN.

Sana Bio Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-
Avg Forecast	$-60.42M	$-54.14M	$-57.09M	$-56.50M	$-56.34M	$-60.53M	$-68.46M
High Forecast	$-60.42M	$-54.14M	$-57.09M	$-56.50M	$-51.44M	$-60.53M	$-68.46M
Low Forecast	$-60.42M	$-54.14M	$-57.09M	$-56.50M	$-61.24M	$-60.53M	$-68.46M
Surprise %	-	-	-	-	-	-	-

Sana Bio's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SANA's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Sana Bio SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-
SG&A	-	-	-	-	-	-	-
Avg Forecast	-	-	-	-	-	-	-
High Forecast	-	-	-	-	-	-	-
Low Forecast	-	-	-	-	-	-	-
Surprise %	-	-	-	-	-	-	-

Sana Bio's average Quarter SG&A projection for undefined is $NaN, based on undefined Wall Street analysts, with a range of $NaN to $NaN. The forecast indicates a NaN% fall compared to SANA last annual SG&A of $NaN (undefined).

Sana Bio EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
# Analysts	-	-	-	-	-	-	-
EPS	-	-	-	-	-	-	-
Avg Forecast	$-0.26	$-0.23	$-0.24	$-0.24	$-0.24	$-0.26	$-0.29
High Forecast	$-0.26	$-0.23	$-0.24	$-0.24	$-0.22	$-0.26	$-0.29
Low Forecast	$-0.26	$-0.23	$-0.24	$-0.24	$-0.26	$-0.26	$-0.29
Surprise %	-	-	-	-	-	-	-

According to undefined Wall Street analysts, Sana Bio's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SANA previous annual EPS of $NaN (undefined).

Sana Bio Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
XFOR	X4 Pharmaceuticals	$0.34	$3.67	979.41%	Buy
NKTX	Nkarta	$2.50	$21.60	764.00%	Buy
ZNTL	Zentalis Pharmaceuticals	$3.13	$21.86	598.40%	Buy
LYEL	Lyell Immunopharma	$1.03	$6.67	547.57%	Hold
LIFE	aTyr Pharma	$1.90	$11.00	478.95%	Buy
OLMA	Olema Pharmaceuticals	$8.28	$28.50	244.20%	Buy
SANA	Sana Bio	$2.53	$8.00	216.21%	Buy
DAWN	Day One Biopharmaceuticals	$13.62	$38.80	184.88%	Buy
APLS	Apellis Pharmaceuticals	$27.49	$74.50	171.01%	Buy
TERN	Terns Pharmaceuticals	$5.60	$14.25	154.46%	Buy
CGEM	Cullinan Oncology	$12.58	$31.50	150.40%	Buy
AMLX	Amylyx Pharmaceuticals	$5.23	$6.67	27.53%	Buy
KYMR	Kymera Therapeutics	$44.05	$51.50	16.91%	Buy
BPMC	Blueprint Medicines	$94.81	$109.71	15.72%	Buy
HOOK	HOOKIPA Pharma	$2.72	$3.00	10.29%	Buy
RVMD	Revolution Medicines, Inc. Warrant	$57.07	$60.63	6.24%	Buy

SANA Forecast FAQ

Is Sana Bio a good buy?

Yes, according to 3 Wall Street analysts, Sana Bio (SANA) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 100.00% of SANA's total ratings.

What is SANA's price target?

Sana Bio (SANA) average price target is $8 with a range of $8 to $8, implying a 216.21% from its last price of $2.53. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Sana Bio stock go up soon?

According to Wall Street analysts' prediction for SANA stock, the company can go up by 216.21% (from the last price of $2.53 to the average price target of $8), up by 216.21% based on the highest stock price target, and up by 216.21% based on the lowest stock price target.

Can Sana Bio stock reach $4?

SANA's average twelve months analyst stock price target of $8 supports the claim that Sana Bio can reach $4 in the near future.

What is Sana Bio's current price target trend?

1 Wall Street analyst forecast a $8 price target for Sana Bio (SANA) this month, up 216.21% from its last price of $2.53. Compared to the last 3 and 12 months, the average price target increased by 216.21% and increased by 295.26%, respectively.

What are Sana Bio's analysts' financial forecasts?

Sana Bio's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-185M (high $-180M, low $-190M), average SG&A $0 (high $0, low $0), and average EPS is $-0.788 (high $-0.768, low $-0.809). SANA's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $0 (high $0, low $0), average EBITDA is $0 (high $0, low $0), average net income is $-228M (high $-228M, low $-228M), average SG&A $0 (high $0, low $0), and average EPS is $-0.969 (high $-0.969, low $-0.969).